Revvity (RVTY) Income from Discontinued Operations (2010 - 2022)

Revvity's (RVTY) quarterly Income from Discontinued Operations came in at 9341000.0 in Q4 2022, up 42.63% YoY from 6549000.0 in Q4 2021, and up 23252.5% on a QoQ basis from 40000.0 in Q3 2022.

Revvity (RVTY) Income from Discontinued Operations (2010 - 2022) Analysis & Trends

Revvity (RVTY) has 13 years of Income from Discontinued Operations data on file, last reported at 9341000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Thermo Fisher Scientific 213.77 Bn 209.71 Bn 8.34 Bn -
2 Danaher 139.78 Bn 135.43 Bn 3.61 Bn -
3 Idexx Laboratories 46.04 Bn 45.85 Bn 779.09 Mn -
4 Agilent Technologies 39.68 Bn 37.88 Bn 990.00 Mn -
5 Iqvia Holdings 39.34 Bn 37.26 Bn 1.44 Bn -
6 Natera 38.75 Bn 37.65 Bn 696.04 Mn -
7 Illumina 29.90 Bn 28.73 Bn 770.00 Mn -
8 Mettler Toledo International 28.58 Bn 28.53 Bn 650.22 Mn -
9 Quest Diagnostics 26.18 Bn 25.55 Bn 1.03 Bn -
10 Revvity 12.81 Bn 11.95 Bn 387.66 Mn -

Historic Data

Download Data
DateValue
Oct 2, 2022 9.34 Mn
Jul 3, 2022 40,000.00
Apr 3, 2022 41,000.00
Oct 3, 2021 6.55 Mn
Jul 4, 2021 38,000.00
Apr 4, 2021 38,000.00
Oct 4, 2020 37,000.00
Jul 5, 2020 51,000.00
Apr 5, 2020 50,000.00
Sep 29, 2019 52,000.00
Jun 30, 2019 54,000.00
Mar 31, 2019 41,000.00
Sep 30, 2018 -1.41 Mn
Jul 1, 2018 59,000.00
Apr 1, 2018 11,000.00
Oct 1, 2017 5.26 Mn
Jul 2, 2017 35.93 Mn
Apr 2, 2017 1.22 Mn
Oct 2, 2016 1.87 Mn
Jul 3, 2016 -1.18 Mn